When an ERISA benefits attorney is defending a plan fiduciary against a breach-of-fiduciary-duty claim, the central question is whether the plan's benefit determinations were made through a full and fair review process. The attorney understands ERISA procedure. The compliance consultant understands regulatory requirements. The actuary understands financial exposure. But none of them can answer the clinical question at the center of the case: were the criteria correctly applied?
That question can only be answered by someone who has actually applied the criteria. Not someone who has read the criteria manual. Not someone who has attended a training on criteria interpretation. Someone who has opened a chart, read the clinical evidence, selected the applicable criteria screen, and made a determination — thousands of times, under production conditions, with quality audits and peer review. The operational experience is the credential, because the question is operational.
What the compliance attorney cannot see
A compliance attorney reviewing a denial for ERISA fiduciary defense reads the denial letter, reads the criteria cited, reads the clinical record, and assesses whether the denial appears to follow the plan's stated process. What the compliance attorney cannot assess is whether the criteria were correctly selected — whether the reviewer navigated to the right criteria screen for the clinical presentation — because the compliance attorney does not have the operational experience to know what "correct navigation" looks like in an InterQual or MCG criteria system.
Criteria systems are not simple checklists. They are branching decision trees with condition-specific screens, procedure-specific sub-screens, level-of-care differentiations, and complication modifiers. A reviewer who selects the general medical admission screen instead of the post-surgical admission screen will reach a different criteria threshold. A reviewer who selects psychological screening criteria instead of neuropsychological testing criteria will assess against a different clinical standard. These are not clinical judgment calls — they are navigation decisions in a complex criteria architecture, and getting them wrong means the entire denial is built on the wrong foundation.
A compliance attorney looking at a denial letter that cites "MCG criteria for inpatient admission" has no way to determine whether the reviewer selected the correct MCG criteria screen. A physician who has spent two years navigating those screens can identify the error in thirty seconds.
What the actuary cannot quantify
An actuary can calculate the financial exposure from a pattern of overturned denials. What the actuary cannot determine is whether the overturned denials reflect a criteria application problem or a clinical judgment problem. The distinction matters because the remediation is different.
If denials are being overturned because reviewers are selecting the wrong criteria screens, the fix is reviewer training and criteria-selection oversight. If denials are being overturned because reviewers are applying the correct criteria but reaching clinically unreasonable conclusions, the fix is clinical quality management. If denials are being overturned because the plan's supplemental policies bypass clinical criteria entirely, the fix is structural — the supplemental policies need to be replaced with criteria-based assessments.
An actuary examining a 30% overturn rate sees a number. A UM physician examining the same 30% can tell you which of the three root causes is driving it — because the physician recognizes the error patterns from having made and corrected the same types of determinations under operational conditions.
The specific value in fiduciary defense
In an ERISA fiduciary proceeding, the plan sponsor needs to demonstrate that benefit determinations were made through a clinically sound process. The physician auditor provides three things that no other consultant can provide:
Pattern diagnosis. Were the criteria correctly applied across the denial sample, or is there a systematic error? The physician can distinguish between random reviewer errors (quality management issue) and systematic criteria misapplication (program design issue). The legal significance is different: random errors do not necessarily constitute a fiduciary breach. Systematic misapplication is much harder to defend.
Defensibility grading. For each denial category, the physician can grade clinical defensibility — not legal defensibility, which is the attorney's assessment, but clinical defensibility: would this denial survive review by another qualified physician reviewer? This is the question that an IRO reviewer, a DOL auditor, or an opposing expert will ultimately be answering. A physician who has been in that reviewer role can predict the answer.
Remediation specificity. When the audit identifies deficiencies, the physician can specify exactly what needs to change — which supplemental policies to retire, which criteria navigation training to implement, which peer-to-peer documentation standards to adopt. A compliance attorney can say "the process needs improvement." A UM physician can say "the reviewer needs to select the surgical-specific criteria screen instead of the general admission screen, and the P2P documentation needs to record what clinical information the treating physician provided."
Why the credential matters to ERISA benefits attorneys specifically
ERISA benefits attorneys are a specialized practice. They understand that fiduciary defense is won or lost on the administrative record — the documentation of the plan's decision-making process, not the outcome of individual claims. What they need from a clinical consultant is not a second opinion on the clinical merits. They need a process audit: was the review process clinically sound, and if not, what specifically was deficient?
That process audit requires someone who has conducted the same process. The analogy is straightforward: if you needed to assess whether a surgical procedure was performed competently, you would retain a surgeon who has performed the procedure — not a hospital administrator who has read the procedure manual. The same logic applies to utilization review. Assessing whether criteria were competently applied requires someone who has competently applied them.
Medisprudence exists because that specific professional experience — payer-side utilization review under InterQual and MCG, across thousands of US commercial claims — is extremely rare outside of active UM operations. And active UM physicians inside those operations are not available for attorney-directed consulting work. The gap between "someone who has done this" and "someone who understands this conceptually" is the gap that Medisprudence fills.
Clinical Denial Pattern Audit or MHPAEA Parity Review
The physician-authored process audit described in this essay — applied to your client's specific denial sample or plan criteria. The deliverable an ERISA benefits attorney needs and no other consultant can produce.
Request Compliance Engagement